Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
SWX:NOVN
Novartis
|
90.00 | 13.6% | 27.68% | 181,473.74 | 3.7% | 4.67% |
|
SWX:ROG
Roche Holding
|
218.80 | 33.78% | 50.08% | 178,763.82 | 4.32% | 0.43% |
|
NYSE:A
Agilent Technologies
|
136.37 | 19.17% | 32.57% | 38,897.23 | 0.69% | 14.29% |
|
NasdaqGS:ILMN
Illumina
|
121.05 | 0% | 0% | 19,567.71 | 0% | -34.68% |
|
NasdaqGS:HOLX
Hologic
|
75.71 | -20.66% | -13.98% | 17,694.06 | 0% | 12.17% |
|
NYSE:LH
Laboratory Corp of America Holdings
|
198.35 | -7.14% | 2.83% | 16,949.68 | 1.39% | 4.24% |
|
NYSE:DGX
Quest Diagnostics
|
135.42 | -6.34% | 2.76% | 15,275.76 | 2.18% | 6.66% |
|
ENXTPA:ERF
Eurofins Scientific
|
57.50 | 14.88% | 30.25% | 10,961.88 | 0.88% | 7.46% |
|
NasdaqGS:NTRA
Natera
|
91.28 | 0% | 0% | 10,298.23 | 0% | 0% |
|
NYSE:QGEN
QIAGEN N.V.
|
41.08 | 14.89% | 26.17% | 8,894.11 | 0% | 8.88% |
|
ASX:SHL
Sonic Healthcare
|
26.74 | -0.5% | 20.78% | 13,605.38 | 3.89% | 5.68% |
|
NYSE:BIO
Bio-Rad Laboratories Inc
|
275.60 | 68.31% | 94.94% | 8,762.52 | 0% | 14.59% |
|
NasdaqGS:TXG
10x Genomics
|
27.52 | 0% | 0% | 5,773.62 | 0% | 0% |
|
NasdaqGS:TWST
Twist Bioscience
|
30.75 | 0% | 0% | 2,399.45 | 0% | 0% |
|
NasdaqGS:GH
Guardant Health
|
18.10 | 0% | 0% | 2,363.66 | 0% | 0% |
|
NasdaqCM:NEO
NeoGenomics
|
14.03 | -,118.08% | -76.45% | 1,899.24 | 0% | 0% |
|
NasdaqGS:SDGR
Schrödinger
|
24.04 | 0% | 0% | 1,756.42 | 0% | 0% |
|
NasdaqGS:MYGN
Myriad Genetics
|
18.63 | -,100.23% | -85.76% | 1,673.85 | 0% | 0% |
|
NasdaqGM:VCYT
Veracyte
|
19.90 | 0% | 0% | 1,460.07 | 0% | 0% |
|
NasdaqGS:OPK
OPKO Health
|
1.01 | 0% | 0% | 1,182.78 | 0% | -,200% |
